Literature DB >> 2180598

Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease.

Y Niwa1, Y Mizushima.   

Abstract

The potentiating effect of the soluble factors released from normal or diseased lymphocytes on neutrophil functions were investigated in the presence or absence of mitogens and wall preparations of Streptococcus pyogenes. When normal T lymphocyte populations were stimulated with T cell mitogens or with streptococcal preparations, the supernatants from these cultures potentiated neutrophil chemotaxis, phagocytosis and O2- generation. Upon gel-filtration of these stimulated lymphocyte supernatants, the neutrophil-potentiating activity was inactivated by trypsin or by a 30-min incubation at 130 degrees C, but was not affected by acid treatment at pH 2 or heat treatment at 56 degrees C for 60 min. Its activity was almost not affected by antisera against human interleukin-1, interleukin-2, interferon-gamma or tumour necrosis factor. With the stimulation of T cell mitogens, the supernatants released from the lymphocytes of not only the patients with Behçet's disease but also healthy and diseased controls enhanced neutrophil functions. However, supernatants from streptococcal preparation-stimulated lymphocytes from patients with Behçet's disease had a higher potentiating effect on neutrophil functions. Our study suggests that the enhanced neutrophil functions in patients with Behçet's disease may be related to an abnormally high level of circulating activated T cells in these patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180598      PMCID: PMC1534946          DOI: 10.1111/j.1365-2249.1990.tb08095.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Analysis of interleukin-2 activity in patients with Behçet's disease. Ability of T cells to produce and respond to interleukin-2.

Authors:  T Sakane; N Suzuki; Y Ueda; S Takada; Y Murakawa; T Hoshino; Y Niwa; T Tsunematsu
Journal:  Arthritis Rheum       Date:  1986-03

Review 2.  T-cell growth factor and the culture of cloned functional T cells.

Authors:  K A Smith; F W Ruscetti
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

3.  Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen.

Authors:  M S Klempner; C A Dinarello; W R Henderson; J I Gallin
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

4.  Decrease in generation of reactive oxygen species by neutrophils from patients with infectious mononucleosis: role of suppressor T lymphocytes.

Authors:  Y Niwa; T Sakane; Y Miyachi; T Kanoh; K Somiya
Journal:  Blood       Date:  1984-11       Impact factor: 22.113

5.  Effect of recombinant DNA-produced tumor necrosis factor on various parameters of neutrophil function.

Authors:  Y Ozaki; T Ohashi; Y Niwa; S Kume
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

6.  Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits.

Authors:  F Goto; S Nakamura; K Goto; M Yoshinaga
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

7.  Effect of stimulated neutrophils from the synovial fluid of patients with rheumatoid arthritis on lymphocytes--a possible role of increased oxygen radicals generated by the neutrophils.

Authors:  Y Niwa; T Sakane; M Shingu; M M Yokoyama
Journal:  J Clin Immunol       Date:  1983-07       Impact factor: 8.317

8.  Effect of interleukin 1 on chemotaxis and chemiluminescence of human neutrophils.

Authors:  T Terui; T Kato; R Suzuki; K Kumagai; H Tagami
Journal:  Tohoku J Exp Med       Date:  1986-07       Impact factor: 1.848

9.  Species-specificity of T cell stimulating activities of IL 2 and BSF-1 (IL 4): comparison of normal and recombinant, mouse and human IL 2 and BSF-1 (IL 4).

Authors:  T R Mosmann; T Yokota; R Kastelein; S M Zurawski; N Arai; Y Takebe
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

10.  Antigen-mediated interleukin production by mononuclear cells from delayed hypersensitive mice.

Authors:  K Kobayashi; S Cohen; T Yoshida
Journal:  J Exp Pathol       Date:  1985
View more
  7 in total

Review 1.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

Review 2.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

3.  New approaches in immunotherapy of behçet disease.

Authors:  Fatemeh Zare Shahneh; Mozhdeh Mohammadian; Zohreh Babaloo; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2013-02-07

4.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

5.  The role of an uncommon type of oral streptococcus sanguis in the etiology of behcet's disease.

Authors:  M Tsuchida; S Mineshita; H Okonogi; K Sugimori; K Hoshi; T Horiuchi; L M Wang; E K Fujimoto
Journal:  Environ Health Prev Med       Date:  1997-07       Impact factor: 3.674

6.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

7.  Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.

Authors:  Kuddusi Erkiliç; Cem Evereklioglu; Mustafa Cekmen; Abdullah Ozkiris; Fuat Duygulu; Hakki Dogan
Journal:  Mediators Inflamm       Date:  2003-04       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.